<section id ="1036520-1309683" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2017, c. 6, s. 49</h2></header><div class="modal-body"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">1993, c. 2, s. 7</span></p><ul class="Section ProvisionList" id="1036520"><li><p class="Subsection amending" id="1036523"><strong><a class="sectionLabel" id="s-49"><span class="sectionLabel">49</span></a></strong> <span class="lawlabel">(1)</span> Subsections 82(1) and (2) of the Act are replaced by the following:</p><section><div class="AmendedText"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Notice of introductory price</p><ul class="Section ProvisionList" id=""><li><p class="Subsection"><strong>82</strong> <span class="lawlabel">(1)</span> A rights holder for an invention pertaining to a medicine who intends to sell the medicine in a market in Canada in which it has not previously been sold shall, as soon as practicable after determining the date on which the medicine will be first offered for sale in that market, notify the Board of its intention and of that date.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Pricing information and documents</p><p class="Subsection"><span class="lawlabel">(2)</span> If the Board receives a notice under subsection (1) from a rights holder or otherwise has reason to believe that a rights holder for an invention pertaining to a medicine intends to sell the medicine in a market in Canada in which the medicine has not previously been sold, the Board may, by order, require the rights holder to provide the Board with information and documents respecting the price at which the medicine is intended to be sold in that market.</p></li></ul></div></section></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">1993, c. 2, s. 7</span></p><p class="Subsection amending" id="1036525"><span class="lawlabel">(2)</span> Subsection 82(3) of the English version of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="Section ProvisionList" id=""><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Compliance with order</p><p class="Subsection"><span class="lawlabel">(3)</span> Subject to subsection (4), a rights holder in respect of whom an order is made under subsection (2) shall comply with the order within the time that is specified in the order or as the Board may allow.</p></li></ul></div></section></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">1993, c. 2, s. 7</span></p><p class="Subsection amending" id="1036529"><span class="lawlabel">(3)</span> Subsection 82(4) of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="Section ProvisionList" id=""><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Limitation</p><p class="Subsection"><span class="lawlabel">(4)</span> No rights holder shall be required to comply with an order made under subsection (2) prior to the 60th day preceding the date on which the rights holder intends to first offer the medicine for sale in the relevant market.</p></li></ul></div></section></li></ul></div></section>